Sector Update: Health Care Stocks Steady Pre-Bell Wednesday

MT Newswires Live

Sep 24

Health care stocks were steady pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) a slight 0.1% higher and the iShares Biotechnology ETF (IBB) inactive.

Acadia Pharmaceuticals (ACAD) stock was down more than 11% after the company said its ACP-101, or intranasal carbetocin, therapy candidate for patients with hyperphagia in Prader-Willi syndrome did not meet its primary efficacy endpoint in a phase 3 trial.

Soleno Therapeutics (SLNO) shares were up more than 13% after a rival therapy from Acadia Pharmaceuticals failed to meet its primary endpoint in a phase 3 trial.

UniQure (QURE) stock was up more than 153% after the company said its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured by the composite Unified Huntington's Disease Rating Scale.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2569704002"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569704002\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569704002?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-24 21:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569704002","market":"sg","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Steady Pre-Bell Wednesday","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were steady pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) a slight 0.1% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) inactive.</p><p>Acadia Pharmaceuticals (ACAD) stock was down more than 11% after the company said its ACP-101, or intranasal carbetocin, therapy candidate for patients with hyperphagia in Prader-Willi syndrome did not meet its primary efficacy endpoint in a phase 3 trial.</p><p><a href=\"https://laohu8.com/S/SLNO\">Soleno Therapeutics</a> (SLNO) shares were up more than 13% after a rival therapy from Acadia Pharmaceuticals failed to meet its primary endpoint in a phase 3 trial.</p><p>UniQure (QURE) stock was up more than 153% after the company said its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured by the composite Unified Huntington's Disease Rating Scale.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Steady Pre-Bell Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Steady Pre-Bell Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-24 21:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were steady pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) a slight 0.1% higher and the <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) inactive.</p><p>Acadia Pharmaceuticals (ACAD) stock was down more than 11% after the company said its ACP-101, or intranasal carbetocin, therapy candidate for patients with hyperphagia in Prader-Willi syndrome did not meet its primary efficacy endpoint in a phase 3 trial.</p><p><a href=\"https://laohu8.com/S/SLNO\">Soleno Therapeutics</a> (SLNO) shares were up more than 13% after a rival therapy from Acadia Pharmaceuticals failed to meet its primary endpoint in a phase 3 trial.</p><p>UniQure (QURE) stock was up more than 153% after the company said its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured by the composite Unified Huntington's Disease Rating Scale.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IBB","symbol_name":"生物科技指数ETF-iShares Nasdaq","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569704002","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569704002","pubTimestamp":1758719538,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were steady pre-bell Wednesday, with the Health Care Select Sector SPDR Fund  a slight 0.1% higher and the iShares Biotechnology ETF  inactive.Acadia Pharmaceuticals  stock was down more than 11% after the company said its ACP-101, or intranasal carbetocin, therapy candidate for patients with hyperphagia in Prader-Willi syndrome did not meet its primary efficacy endpoint in a phase 3 trial.Soleno Therapeutics  shares were up more than 13% after a rival therapy from Acadia Pharmaceuticals failed to meet its primary endpoint in a phase 3 trial.UniQure  stock was up more than 153% after the company said its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured by the composite Unified Huntington's Disease Rating Scale.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IBB":"生物科技指数ETF-iShares Nasdaq","ACAD":"阿卡迪亚","XBI":"SPDR S&P Biotech ETF","LU2065171402.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) INC","LU2065169927.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) ACC","BK4581":"高盛持仓","LABU":"三倍做多标普生物-Direxion","BK4588":"碎股","SLNO":"Soleno Therapeutics","QURE":"uniQure N.V.","BK4585":"ETF&股票定投概念","LU2065171311.SGD":"M&G (LUX) GLOBAL MAXIMA \"A\" (SGD) ACC","LU2065170008.USD":"M&G (LUX) GLOBAL MAXIMA \"A\" (USD) INC","XLV":"健康照护类股ETF-SPDR","BK4139":"生物科技"},"translate_title":"行业更新：医疗保健股周三盘前稳定","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACAD":1,"IBB":1,"LABU":0.6,"QURE":1,"SLNO":1,"XBI":0.6,"XLV":1},"content_text":"Health care stocks were steady pre-bell Wednesday, with the Health Care Select Sector SPDR Fund (XLV) a slight 0.1% higher and the iShares Biotechnology ETF (IBB) inactive.Acadia Pharmaceuticals (ACAD) stock was down more than 11% after the company said its ACP-101, or intranasal carbetocin, therapy candidate for patients with hyperphagia in Prader-Willi syndrome did not meet its primary efficacy endpoint in a phase 3 trial.Soleno Therapeutics (SLNO) shares were up more than 13% after a rival therapy from Acadia Pharmaceuticals failed to meet its primary endpoint in a phase 3 trial.UniQure (QURE) stock was up more than 153% after the company said its phase 1/2 study in Huntington's disease met its primary endpoint, with high-dose AMT-130 showing statistically significant 75% slowing of disease at 36 months as measured by the composite Unified Huntington's Disease Rating Scale.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}